Royalty Pharma plc financial statements
Royalty Pharma plc's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 2.38B | 10-K |
| Net income | USD 770.95M | 10-K |
| Cash and equivalents | USD 618.7M | 10-Q |
| Total debt | USD 8.95B | 10-Q |
Royalty Pharma plc financials on 6ix · Royalty Pharma plc on 6ix